Rick Jensen Email

Sr. Director, Quality . ARCA biopharma

Current Roles

Employees:
25
Revenue:
$3.5M
About
ARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA biopharma began operations in 2005 and is headquartered in Broomfield, Colorado. The Company’s lead investigational product is Gencaro™ 1 (bucindolol hydrochloride), a genetically-targeted beta-blocker with unique pharmacology, in development for heart failure and other indications. ARCA’s New Drug Application for Gencaro for chronic heart failure, was accepted for filing by the U.S. Food and Drug Administration in September, 2008, and is currently under review by the FDA with a Prescription Drug User Fee Act (PDUFA) date of May 31, 2009.
ARCA biopharma Address
11080 Circlepoint Rd
Broomfield, CO
United States
ARCA biopharma Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.